Clinical trial
Recombinant Human Prolactin for Lactation Induction
NCT00181623 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181623 |
|---|---|
| Title | Recombinant Human Prolactin for Lactation Induction |
| Official title | Recombinant Human Prolactin for Lactation Induction in Prolactin Deficient Mothers |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lactation |
| Intervention type | Drug |
| Interventions | Recombinant Human Prolactin |
| Enrollment | 6 |
| Start date | Jan 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: